Liquidia (LQDA) Stock Price, Quote, News & History | Benzinga

Liquidia Corp (LQDA) Stock Price, Quote, News & History

LQDANASDAQ

Trade with Public

Trade with Public

$74.44

2.343.25%

At close: Aug 14, 5:00 PM EST

$74.41

-0.03-0.04%

After Hours: Aug 14, 4:28 PM EST

Earnings: Q2 2026 Earnings were released on Wed Aug 12th, before the market open

Conference Call: The most recent conference call started at 8:30 AM, 3 days ago

Click to view the webcast

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$71.98

Close

$74.44

Volume / Avg.

2.52M / 1.93M

Day Range

$71.53 - $76.90

52 Wk Range

21.15 - 93.61

Market Cap

$6.62B

P/E Ratio

51.50

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

16.71%

Days to Cover

8.25

Recent Liquidia Corporation News

Brinker International To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

Top analysts changed outlook on top names. Truist, Morgan Stanley, B of A Securities, HC Wainwright, Baird, and Stephens & Co. altered price targets for various stocks.

Avi Kapoor

Applied Materials To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts upgraded and downgraded several top companies, including Applied Materials, Robinhood, Liquidia, Airbnb, Praxis, Alnylam, and Uniqure.

Avi Kapoor

This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrades, and initiations on analyst ratings page.

Avi Kapoor

These Analysts Boost Their Forecasts On Liquidia After Upbeat Q1 Results

Liquidia Corp (LQDA) reported better-than-expected Q1 results, with earnings of 52 cents per share and sales of $132.865 million. Analysts raised price targets on LQDA stock.

Avi Kapoor

Nvidia To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday

Wall Street analysts changed outlook on top names. For full view of analyst rating changes, see analyst ratings page. See how other analysts view these stocks.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

167.71M

Investing Cash Flow (TTM)

-20.01M

Financing Cash Flow (TTM)

-36.94M

Free Cash Flow (TTM)

147.69M

Capital Expenditure (TTM)

-20.01M

Net Change in Cash (TTM)

110.76M

Analyst Trends and Forecast

4

May

2

1

Jun

1

Jul

3

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.57B

PE Ratio (TTM)

51.50

PE Ratio (FWD)

18.15

PEG Ratio (TTM)

-

PS Ratio (TTM)

15.03

PB Ratio (TTM)

33.08

Earnings Yield % (TTM)

1.94%

Earnings Yield % (FWD)

5.51%

EV / EBITDA (TTM)

35.72

Price / EBITDA (TTM)

38.11

Price / Free Cash Flow (TTM)

45.89

Book Value / Share

$2.18

Company Debt

Total Debt

$176.11M

LT Debt

$122.15M

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-$44.14M

Total Cash

$284.18M

Debt to Equity

0.94

Issuance of Debt (TTM)

-$44.14M

Repayment of Debt (TTM)

-$44.14M

Key Statistics

Open

$71.98

Close

$74.44

Volume / Avg.

2.52M / 1.93M

Day Range

$71.53 - $76.90

52 Wk Range

21.15 - 93.61

Market Cap

$6.62B

P/E Ratio

51.50

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

16.71%

Days to Cover

8.25

About

Sector

Health Care

Industry

Pharmaceuticals

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hyperte...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Liquidia (LQDA) stock?

A

You can purchase shares of Liquidia (NASDAQ:LQDA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Liquidia (LQDA) competitors?

A

Other companies in Liquidia’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Liquidia (LQDA) stock?

A

Liquidia has a consensus price target of $58.56.

Q

What is the current price for Liquidia (LQDA)?

A

The stock price for Liquidia (NASDAQ: LQDA) is $74.41 last updated August 14, 2026 at 4:28 PM EDT.

Q

Does Liquidia (LQDA) pay a dividend?

A

There are no upcoming dividends for Liquidia.

Q

When is Liquidia (NASDAQ:LQDA) reporting earnings?

A

Liquidia does not have any upcoming earnings scheduled.

Q

Is Liquidia (LQDA) going to split?

A

There is no upcoming split for Liquidia.

Q

What sector and industry does Liquidia (LQDA) operate in?

A

Liquidia is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.